Resonance Health patent granted
Thursday, 13 October, 2005
Perth based Resonance Health (ASX:RHT) has been granted its first European patent.
The patent protects the core invention underlying the FerriScan test for the non-invasive measurement of liver iron concentration. It is the European equivalent to a US patent granted in 2003 which is also being prosecuted in several other jurisdictions.
The company is also prosecuting a second patent family to expand the company's technology platform.
The intellectual property assets relating to the FerriScan test are fully owned by Resonance Health, following its acquisition of Inner Vision Biometrics in May 2005.
Link between oestrogen and heart health found in women
Scientists found that oestrogen helps increase the ANXA1 protein, and when ANXA1 is missing, the...
Frequent nightmares accelerate aging, increase risk of death
Nghtmares independently predict faster biological aging and earlier mortality — even after...
Cardiac organoids bring hope for treating heart disease
Australian scientists have developed lab-grown, three-dimensional heart tissues known as cardiac...
